Japan Approves Anselamimab for Amyloidosis After Phase 3 Miss; 3 Japanese Kappa Patients Studied
This picture taken on May 20, 2016 shows flasks of mother tincture at Boiron laboratory in Brest, western…
#EuropeSays #Britain #Europe #EU #AstraZeneca #Amilopaive #amyloidosis #Anselamimab #biotech #FDA #FortressBiotech #Japan
https://www.europesays.com/britain/165986/